Choosing Cleanroom Clothing - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Choosing Cleanroom Clothing
PTE quizzes Jaime Cassar, cleanroom category manager at Kimberly-Clark Professional Europe, about the importance of sterile garments for cleanroom environments.

Pharmaceutical Technology Europe
Volume 23, Issue 12

How important is the selection of sterile cleanroom clothing?

Jaime Cassar. Cleanroom category manager at Kimberly-Clark Professional Europe
People are the biggest source of potential contamination to a sterile cleanroom so sterile clothing is crucial. As a basic requirement, sterile clothing must help maintain a cleanroom’s cleanliness while people are working in the area, by ensuring that particle and microbiological levels are kept below the limits for the chosen grade of area, as set in the EU Guidelines to GMP for Sterile Manufacturing. At first glance, this may seem quite straightforward. However, sterile clothing has a direct impact on both contamination control and productivity of a sterile manufacturing process, so several factors beyond the basic requirement need to be considered when selecting clothing.

Sterile clothing should be selected with continuous improvement in mind, with choices made on the basis of either better controlling or eliminating variables that impact contamination control and productivity. Any continuous improvement delivered by sterile clothing will help to improve yields, and protect quality —in this way sterile clothing selection can play an important part of a Quality by Design approach to a sterile manufacturing process. The materials, design features, manufacturing, cleaning, packaging, sterilisation, specification, quality controls, documentation and certification of sterile clothing are all attributes that affect how cleanroom clothing interact with sterile manufacturing processes.

How can the protection provided by sterile clothing help to create process improvements?

The cleanliness of sterile clothing is important to consider in order to prevent the clothing from itself becoming a source of contamination. For example, sterile gloves that have been washed in di-ionised water, cleanroom packed, sterile validated and specified for low endotoxin levels can help lower the risk of particle, microbiological and endotoxin contamination. Sterile apparel that is laundered, cleanroom packed in individual vacuum packaging, double-bagged and provided with periodic sterile validation will also contribute to lower contamination risks. Sterile gloves made from synthetic materials are beneficial because they can eliminate the risk of contaminating the final product with rubber latex proteins, which can be a problem for patients with latex allergies.

Another crucial point is the barrier performance of the clothing. Continuous improvement can come from better control or elimination of variability in attributes that impact barrier performance. For example, disposable apparel eliminates the risk of variability in filtration efficiency and material strength that may come from re-wearing, re-washing and re-sterilising apparel many times and over a long period of time. Sterile apparel made from stronger materials and sterile gloves with a higher quality film formation will be more resistant to breakage and are more likely to be free from any pinhole type defects.

As well as protecting the process from contamination, sterile clothing should also protect the wearer from the health and safety risks presented by chemicals and APIs. Sterile gloves tested to show longer resistance times to permeation by cytotoxic chemicals and sterile clothing certified to provide protection against chemical splashes can contribute to better protection for the wearer. In Europe, sterile gloves and apparel should be Category III certified under the personal protective equipment (PPE) directive 89/686/EEC, if there is risk of exposure to chemicals and APIs. There are also other ways to protect wearers from health and safety risks. For example, sterile clothing that is biocompatible can mitigate the risk of the clothing causing irritation to the wearer, and sterile gloves that are free from natural rubber latex will eliminate the risk of latex allergies.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology Europe,
Click here